GEHC GE HealthCarecompanySEC Filings & Insider Trading Activity 2026
Latest GE HealthCare (GEHC) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 4, 2026, a 10-Q quarterly report filed on October 29, 2025, an 8-K current report filed on April 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for GE HealthCare (GEHC) (SEC CIK 1932393), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: global healthcare solutions provider delivering advanced medical tech, diagnostics, AI, cloud, and software for personalized patient care
- • New emphasis on AI-enabled software solutions upgradeable through equipment lifecycle, enhancing multi-site healthcare network operations
Risk Factors
- • US tariffs on global imports in 2025 materially reduced profitability and cash flows, with ongoing risk of additional tariffs impacting financial results
- • Russia-Ukraine conflict and resulting US, EU sanctions increased costs and restricted supply to Russian customers, with uncertain license approvals from US authorities
Management Discussion & Analysis
- • Revenue $20,625M, up 4.8% YoY; Product sales $13,661M (+4.5%, +$586M), Services $6,964M (+5.6%, +$368M)
- • Operating income $2,763M (13.4% margin vs 13.3%), net income $2,084M (10.1% margin, flat YoY)
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Management Discussion & Analysis
- • Quarterly revenue $5,143M, up 6% YoY from $4,863M; nine-month revenue $14,927M, up 4% YoY from $14,353M
- • Operating margin 12.7% vs 13.9% YoY Q3; nine-month operating margin 13.0% vs 12.7% YoY, net income margin 10.0% vs 8.9% YoY
Risk Factors
- • No material changes to risk factors from fiscal 2024 10-K disclosed this quarter
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Kevin A. Lobo appointed to GE HealthCare Technologies Board of Directors, effective March 17, 2026
- • Lobo brings likely medtech leadership experience — known as former CEO of Stryker Corp, a major medical device peer
Item 5.02: Departure/Appointment of Directors or Principal Officers
- • Kevin Lobo appointed to GEHC Board effective March 13, 2026; also joins Talent, Culture & Compensation Committee
- • Lobo's term runs only through 2026 Annual Meeting — near-term re-election vote will confirm permanent status
Item 1.02: Termination of a Material Definitive Agreement
- • Old $0.5B 364-day senior unsecured revolving credit facility terminated Feb 26, 2026 — replaced by new revolving credit agreement
- • Termination occurred without penalty, signaling clean transition with no early exit costs
Item 1.01: Entry into a Material Definitive Agreement
- • $500M senior unsecured revolving credit facility, 364-day term maturing Feb 25, 2027 — direct replacement of prior $0.5B facility terminated same day
- • Rate options: SOFR, EURIBOR, or SONIA plus margin tied to GEHC's senior unsecured long-term debt ratings — multi-currency capable
Annual Reports Archive10-K
AI-powered analysis of GE HealthCare (GEHC) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of GE HealthCare (GEHC) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of GE HealthCare (GEHC) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | — | $19.6B | $19.7B | $20.6B |
| Gross Profit | $7.2B | $7.9B | $8.2B | $8.2B |
| Operating Income | — | $2.4B | $2.6B | $2.8B |
| Net Income | — | $1.6B | $2.0B | $2.1B |
| Gross Margin | — | 40.5% | 41.7% | 40.0% |
| Op. Margin | — | 12.5% | 13.3% | 13.4% |
| Net Margin | — | 8.0% | 10.1% | 10.1% |
| Balance Sheet | ||||
| Total Assets | $27.5B | $32.5B | $33.1B | $36.9B |
| Equity | — | $7.1B | $8.4B | $10.4B |
| ROE | — | 22.0% | 23.6% | 20.1% |
Source: XBRL financial data from GE HealthCare (GEHC) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 29, 2026 | — | — | — |
8-K | Mar 17, 2026 | — | Analysis | — |
8-K | Feb 27, 2026 | — | Analysis | — |
10-K | Feb 4, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 4, 2026 | — | — | |
8-K | Dec 15, 2025 | — | — | |
8-K | Dec 2, 2025 | — | — | |
10-Q | Oct 29, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Jul 30, 2025 | Jun 30, 2025 | — | |
10-Q | Apr 30, 2025 | Mar 31, 2025 | — | |
10-K | Feb 13, 2025 | Dec 31, 2024 | — | |
10-Q | Oct 30, 2024 | Sep 30, 2024 | — | |
10-Q | Jul 31, 2024 | Jun 30, 2024 | — | |
10-Q | Apr 30, 2024 | Mar 31, 2024 | — | |
10-K | Feb 6, 2024 | Dec 31, 2023 | — | |
10-Q | Oct 31, 2023 | Sep 30, 2023 | — | |
10-Q | Jul 25, 2023 | Jun 30, 2023 | — | |
10-Q | Apr 25, 2023 | Mar 31, 2023 | — | |
10-K | Feb 15, 2023 | Dec 31, 2022 | — |
Frequently Asked Questions
What are the latest GEHC SEC filings in 2026?
GE HealthCare (GEHC) has filed a 10-K annual report on February 4, 2026, a 10-Q quarterly report on October 29, 2025, an 8-K current report on April 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did GEHC file its most recent 10-K annual report?
GE HealthCare (GEHC) filed its most recent 10-K annual report on February 4, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view GEHC 10-Q quarterly reports?
GE HealthCare (GEHC)'s most recent 10-Q quarterly report was filed on October 29, 2025. SignalX displays every GEHC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has GEHC filed recently?
GE HealthCare (GEHC)'s most recent 8-K was filed on April 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find GEHC insider trading activity (Form 4)?
SignalX aggregates every GEHC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does GEHC file with the SEC?
GE HealthCare (GEHC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new GEHC filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for GE HealthCare (GEHC).
What is GEHC's SEC CIK number?
GE HealthCare (GEHC)'s SEC CIK (Central Index Key) number is 1932393. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1932393 to look up all GEHC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find GEHC return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from GE HealthCare (GEHC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of GE HealthCare SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 19+ filings.